- Home
- NWFL vs SLP Comparison
NWFL vs SLP Comparison
Compare NWFL & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NWFL | SLP |
|---|---|---|
| Founded | 1870 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | EDP Services |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 346.2M | 326.7M |
| IPO Year | 1996 | 1996 |
Fundamental Metrics
Financial Performance| Metric | NWFL | SLP |
|---|---|---|
| Price | $32.03 | $16.33 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $33.00 | $24.00 |
| AVG Volume (30 Days) | 13.6K | ★ 192.0K |
| Earning Date | 04-27-2026 | 04-09-2026 |
| Dividend Yield | ★ 4.39% | N/A |
| EPS Growth | ★ 15150.00 | N/A |
| EPS | ★ 0.35 | 0.26 |
| Revenue | $7,999,000.00 | ★ $59,577,000.00 |
| Revenue This Year | $34.35 | $3.80 |
| Revenue Next Year | $5.55 | $5.90 |
| P/E Ratio | $91.17 | ★ $63.42 |
| Revenue Growth | 8.11 | ★ 10.52 |
| 52 Week Low | $23.70 | $11.09 |
| 52 Week High | $32.23 | $21.01 |
Technical Indicators
Market Signals| Indicator | NWFL | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 65.24 | 57.01 |
| Support Level | $28.95 | $16.26 |
| Resistance Level | N/A | $17.32 |
| Average True Range (ATR) | 0.71 | 0.84 |
| MACD | 0.22 | -0.04 |
| Stochastic Oscillator | 100.00 | 46.62 |
Price Performance
Historical ComparisonAbout NWFL Norwood Financial Corp.
Norwood Financial Corp is a U.S.-based bank holding company. It offers various personal and business credit services, trust and investment products, and real estate settlement services to consumers, businesses, nonprofit organizations, and municipalities in each of the communities that the bank serves. The bank also manages automated teller machines at its branch location. It serves the Pennsylvanian counties of Wayne, Pike, Monroe, and Lackawanna, as well as Susquehanna County.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.